DarioHealth Corp DRIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DRIO is a good fit for your portfolio.
News
-
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
-
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
-
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
-
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
-
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
-
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
-
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
-
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
Trading Information
- Previous Close Price
- $1.52
- Day Range
- $1.51–1.59
- 52-Week Range
- $0.68–4.58
- Bid/Ask
- $1.23 / $1.88
- Market Cap
- $46.59 Mil
- Volume/Avg
- 52,600 / 124,248
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.19
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 252
- Website
- https://www.mydario.com
Comparables
Valuation
|
Metric
|
DRIO
|
SENS
|
AVDX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 114.96 |
Price/Book Value | 0.73 | 7.48 | 3.77 |
Price/Sales | 2.19 | 12.81 | 6.43 |
Price/Cash Flow | — | — | 79.91 |
Price/Earnings
DRIO
SENS
AVDX
Financial Strength
|
Metric
|
DRIO
|
SENS
|
AVDX
|
|---|---|---|---|
Quick Ratio | 3.24 | 6.72 | 0.30 |
Current Ratio | 3.79 | 7.53 | 1.25 |
Interest Coverage | — | −4.92 | −3.96 |
Quick Ratio
DRIO
SENS
AVDX
Profitability
|
Metric
|
DRIO
|
SENS
|
AVDX
|
|---|---|---|---|
Return on Assets (Normalized) | −28.67% | −46.35% | 0.57% |
Return on Equity (Normalized) | −43.99% | −179.13% | 1.89% |
Return on Invested Capital (Normalized) | −32.81% | −72.63% | 0.81% |
Return on Assets
DRIO
SENS
AVDX
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Xyllktx | $36.3 Bil | |
VEEV
| Veeva Systems Inc Class A | Kdzjlpxv | Ktlfj | $32.9 Bil | |
SOLV
| Solventum Corp | — | Zsfpkf | $11.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Nmvmq | $7.8 Bil | |
MTHRF
| M3 Inc | — | Lsxqc | $7.3 Bil | |
MTHRY
| M3 Inc ADR | — | Smbwrfw | $7.3 Bil | |
HQY
| HealthEquity Inc | — | Nxcff | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Fztlg | $5.2 Bil | |
DOCS
| Doximity Inc Class A | — | Ggpncn | $4.5 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Fjyz | $3.3 Bil |